speb/financial-data huggingface dataset:
BAFN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -24000.00
BAFN cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
BAFN cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -50000000.00
BAFN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 74989000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 74989000.00
BAFN income_statement (annual, 2025-12-31) — Normalized Income: -17518448.00
BAFN income_statement (quarterly, 2025-12-31) — Normalized Income: -2444671.51
BAFN income_statement (annual, 2025-12-31) — Occupancy And Equipment: 6068000.00
BAFN income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 1330000.00
BAFN cash_flow (annual, 2025-12-31) — Operating Cash Flow: 285295000.00
BAFN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 100531000.00
BAFN cash_flow (annual, 2025-12-31) — Operating Gains Losses: -10527000.00
BAFN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 2122000.00
BAFN income_statement (annual, 2025-12-31) — Operating Revenue: 56180000.00
BAFN income_statement (quarterly, 2025-12-31) — Operating Revenue: 9919000.00
BAFN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 5368961.00
BAFN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 5368961.00
BAFN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1960000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1960000.00
BAFN balance_sheet (annual, 2025-12-31) — Other Equity Interest: -335000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -335000.00
BAFN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 12580000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 12580000.00
BAFN cash_flow (annual, 2025-12-31) — Other Non Cash Items: 298685000.00
BAFN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 287257000.00
BAFN income_statement (annual, 2025-12-31) — Other Non Interest Expense: 13247000.00
BAFN income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 3136000.00
BAFN balance_sheet (annual, 2025-12-31) — Other Properties: 14504000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Other Properties: 14504000.00
BAFN balance_sheet (annual, 2025-12-31) — Payables: 1133000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Payables: 1133000.00
BAFN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1133000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1133000.00
BAFN balance_sheet (annual, 2025-12-31) — Preferred Stock: 15730000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 15730000.00
BAFN cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -771000.00
BAFN cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: 0.00
BAFN income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 1541000.00
BAFN income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 385000.00
BAFN balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 15730000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 15730000.00
BAFN income_statement (annual, 2025-12-31) — Pretax Income: -30830000.00
BAFN income_statement (quarterly, 2025-12-31) — Pretax Income: -2822000.00
BAFN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 193000.00
BAFN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -175000.00
BAFN income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 3456000.00
BAFN income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 1083000.00
BAFN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -5848000.00
BAFN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 2372000.00
BAFN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -300000.00
BAFN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -24000.00
BAFN balance_sheet (annual, 2025-12-31) — Receivables: 8421000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Receivables: 8421000.00
BAFN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 9116000.00
BAFN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2099000.00
BAFN cash_flow (annual, 2025-12-31) — Repayment Of Debt: -341000.00
BAFN cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
BAFN cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -335000.00
BAFN cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
BAFN income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 7283000.00
BAFN income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 21000.00
BAFN balance_sheet (annual, 2025-12-31) — Retained Earnings: 19763000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 19763000.00
BAFN income_statement (annual, 2025-12-31) — Salaries And Wages: 30937000.00
BAFN income_statement (quarterly, 2025-12-31) — Salaries And Wages: 4883000.00
BAFN cash_flow (annual, 2025-12-31) — Sale Of Investment: 13983000.00
BAFN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 634000.00
BAFN cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
BAFN income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1433000.00
BAFN income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 281000.00
BAFN income_statement (annual, 2025-12-31) — Selling General And Administration: 32370000.00
BAFN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 5164000.00
BAFN balance_sheet (annual, 2025-12-31) — Share Issued: 5368961.00
BAFN balance_sheet (quarterly, 2025-12-31) — Share Issued: 5368961.00
BAFN cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
BAFN income_statement (annual, 2025-12-31) — Special Income Charges: -7283000.00
BAFN income_statement (quarterly, 2025-12-31) — Special Income Charges: -21000.00
BAFN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 116000.00
BAFN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: -40000.00
BAFN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 87569000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 87569000.00
BAFN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 59259000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 59259000.00
BAFN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1864448.00
BAFN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -2671.51
BAFN income_statement (annual, 2025-12-31) — Tax Provision: -7893000.00
BAFN income_statement (quarterly, 2025-12-31) — Tax Provision: -359000.00
BAFN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.26
BAFN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.13
BAFN balance_sheet (annual, 2025-12-31) — Total Assets: 1300258000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Total Assets: 1300258000.00
BAFN balance_sheet (annual, 2025-12-31) — Total Capitalization: 95124000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 95124000.00
BAFN balance_sheet (annual, 2025-12-31) — Total Debt: 20819000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Total Debt: 20819000.00
BAFN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 87569000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 87569000.00
BAFN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1212689000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1212689000.00
BAFN income_statement (annual, 2025-12-31) — Total Unusual Items: -7283000.00
BAFN income_statement (quarterly, 2025-12-31) — Total Unusual Items: -21000.00
BAFN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -7283000.00
BAFN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -21000.00
BAFN income_statement (quarterly, 2026-03-31) — +Total Revenue: 6484000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 958000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 7683000.00
BAFN cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 1246000.00
BAFN cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 1246000.00
BAFN cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 1249000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 28531000.00
BAFN income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 0.00
BAFN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 5355767.00
BAFN income_statement (quarterly, 2026-03-31) — Basic EPS: -1.13
BAFN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 206982000.00
BAFN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 13003000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 70120000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 134465000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 139127000.00
BAFN cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
BAFN balance_sheet (quarterly, 2026-03-31) — Cash Financial: 6848000.00
BAFN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -98165000.00
BAFN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 28854000.00
BAFN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -3206000.00
BAFN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -175000.00
BAFN cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 2874000.00
BAFN cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -472000.00
BAFN cash_flow (quarterly, 2026-03-31) — Change In Payable: -175000.00
BAFN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -175000.00
BAFN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 738000.00
BAFN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2965000.00
BAFN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 738000.00
BAFN cash_flow (quarterly, 2026-03-31) — Changes In Cash: -72517000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Common Stock: 54390000.00
BAFN cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: 0.00
BAFN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 66137000.00
BAFN cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 18000.00
BAFN cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
BAFN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -7221000.00
BAFN cash_flow (quarterly, 2026-03-31) — Deferred Tax: -7221000.00
BAFN cash_flow (quarterly, 2026-03-31) — Depreciation: 518000.00
BAFN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1764000.00
BAFN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1764000.00
BAFN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 5355767.00
BAFN income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.13
BAFN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -6065000.00
BAFN cash_flow (quarterly, 2026-03-31) — End Cash Position: 134465000.00
BAFN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -98165000.00
BAFN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -3213000.00
BAFN cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -13000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2054000.00
BAFN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5860000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 11334000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 44861000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 2491000.00
BAFN cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 3000.00
BAFN income_statement (quarterly, 2026-03-31) — Insurance And Claims: 162000.00
BAFN income_statement (quarterly, 2026-03-31) — Interest Expense: 7990000.00
BAFN income_statement (quarterly, 2026-03-31) — Interest Income: 17439000.00
BAFN cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 8165000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 73715000.00
BAFN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 28854000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 31022000.00
BAFN cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 18000.00
BAFN cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
BAFN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 13003000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7578000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 20581000.00
BAFN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -114000.00
BAFN cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 18000.00
BAFN income_statement (quarterly, 2026-03-31) — Net Income: -5680000.00
BAFN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -6065000.00
BAFN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -5680000.00
BAFN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -5680000.00
BAFN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -5680000.00
BAFN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -5680000.00
BAFN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -5680000.00
BAFN income_statement (quarterly, 2026-03-31) — Net Interest Income: 9449000.00
BAFN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 698000.00
BAFN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -114000.00
BAFN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -114000.00
BAFN cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 59000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Net PPE: 44861000.00
BAFN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -7000.00
BAFN cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
BAFN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 70533000.00
BAFN income_statement (quarterly, 2026-03-31) — Normalized Income: -5689675.90
BAFN income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 1368000.00
BAFN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -3206000.00
BAFN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 617000.00
BAFN income_statement (quarterly, 2026-03-31) — Operating Revenue: 6484000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 5368965.00
BAFN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2054000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -282000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 11334000.00
BAFN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 609000.00
BAFN income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 2535000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Other Properties: 44861000.00
BAFN income_statement (quarterly, 2026-03-31) — Other Special Charges: -13000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Payables: 958000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 958000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 15730000.00
BAFN cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: 0.00
BAFN income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 385000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 15730000.00
BAFN income_statement (quarterly, 2026-03-31) — Pretax Income: -7631000.00
BAFN income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 1164000.00
BAFN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -6000.00
BAFN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -7000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Receivables: 7683000.00
BAFN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1764000.00
BAFN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -114000.00
BAFN cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
BAFN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 14083000.00
BAFN income_statement (quarterly, 2026-03-31) — Salaries And Wages: 5698000.00
BAFN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 704000.00
BAFN income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 123000.00
BAFN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5983000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Share Issued: 5368965.00
BAFN cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
BAFN income_statement (quarterly, 2026-03-31) — Special Income Charges: 13000.00
BAFN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 54000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 81867000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 54803000.00
BAFN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 3324.10
BAFN income_statement (quarterly, 2026-03-31) — Tax Provision: -1951000.00
BAFN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
BAFN balance_sheet (quarterly, 2026-03-31) — Total Assets: 1195910000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 89445000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Total Debt: 20581000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 81867000.00
BAFN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1114043000.00
BAFN income_statement (quarterly, 2026-03-31) — Total Unusual Items: 13000.00
BAFN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 13000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — +Operating Expense: 272514000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — +Total Revenue: 851403000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 124049000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 147796000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -490929000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 753765000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 23656000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Basic EPS: 2.21
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 18037000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 245708000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -75412000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 236563000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 194000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 194000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 194000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -48372000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -35641000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 139000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Change In Payable: 122177000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -61862000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -7953000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -16307000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Common Stock: 236563000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 619637000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 0.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 512805000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Current Assets: 508798000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Current Debt: 57424000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 57424000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 220127000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Depreciation: 54933000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 54933000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 54933000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 54933000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 23656000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Diluted EPS: 2.21
BAFNAPH.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 52163000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — EBIT: 57405000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — EBITDA: 112338000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — End Cash Position: 1730000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -48148000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 32437000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 21871000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 0.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 19918000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Goodwill: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 147796000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 879387000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Gross Profit: 338598000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Interest Expense: 5242000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 5242000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Interest Income: 336000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 336000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -882000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 149000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Inventory: 202805000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 730231000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -65442000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 0.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1932000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 53170000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 53170000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 500598000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Net Debt: 110400000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Income: 52163000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 52163000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 52163000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 0.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Income Extraordinary: -21565000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 52163000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 52163000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 51923000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 52163000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: 0.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Interest Income: -7602000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -47266000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -47266000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -7602000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 9820000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 9821000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Net PPE: 388458000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -75412000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -98037000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 619637000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 8512000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 9656000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 4192000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 133550000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Normalized Income: 73375000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 97283000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Operating Income: 66084000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Operating Revenue: 851403000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 23656335.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 161658000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 21491000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 392240000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 36734000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 82000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: -2000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 10656000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 11281000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 30167000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Payable: 21493000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Properties: 131149000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 967000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Other Special Charges: 21455000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Payables: 146441000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15606000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 8178000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Pretax Income: 52163000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: 0.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -75412000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 158489000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 512805000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 54933000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 1920000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 1920000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Research And Development: 14683000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 1536000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -659740000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 0.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 5851000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 25769000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Share Issued: 23656335.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Special Income Charges: -21212000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 619637000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 619637000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Tax Provision: 0.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 147322000.00
BAFNAPH.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -1702000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Total Assets: 901446000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 672807000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Total Debt: 110594000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 619637000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Total Expenses: 785319000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 281809000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 392648000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 61682000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 2696000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 899000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -21212000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -21212000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 21167000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Work In Process: 11879000.00
BAFNAPH.NS balance_sheet (annual, 2022-03-31) — Working Capital: 288671000.00
BAFNAPH.NS income_statement (annual, 2022-03-31) — Write Off: -243000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — +Operating Expense: 266875000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — +Total Revenue: 1153499000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 284607000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 411485000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -544271000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 753765000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -3686000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 5418000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 23656000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Basic EPS: 4.79
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1730000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 250776000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -82187000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 236563000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 78094000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 78094000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 76799000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 1295000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -19391000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -12071000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 4479000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Change In Payable: 160558000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -269993000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -144202000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 76364000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Common Stock: 236563000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 734546000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 0.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 765940000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Current Assets: 873117000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Current Debt: 144906000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 144906000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 464763000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 12550000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Depreciation: 53344000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 53344000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 53344000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 53344000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 23656000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Diluted EPS: 4.79
BAFNAPH.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 113380000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — EBIT: 134138000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — EBITDA: 187482000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — End Cash Position: 78094000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 101771000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 21945000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -32662000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -1964000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 14803000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 15000000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 415171000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 946571000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Gross Profit: 387559000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Interest Expense: 17975000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 17975000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Interest Income: 445000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 445000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -16874000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 291000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Inventories Adjustments Allowances: 0.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Inventory: 222196000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 963785000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -74932000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 0.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1932000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 84333000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 84333000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 552547000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Net Debt: 151145000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Net Income: 113380000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 113380000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 113380000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 113380000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 113380000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 116163000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 113380000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -15000000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Net Interest Income: -19931000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 118645000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 118645000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -19931000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 5000000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Net PPE: 402300000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -65223000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 719546000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 12190000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 5418000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 187033000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Normalized Income: 112941757.01
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 49525000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Operating Income: 120684000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Operating Revenue: 1153499000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 23656335.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 156048000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 21200000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 497983000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 15000000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 16690000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -3000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 187000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 38622000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Other Payable: 20500000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Other Properties: 141316000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 547000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Other Special Charges: -3493000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Payables: 305919000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6291000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 18106000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Pretax Income: 116163000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 7727000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -67187000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 148773000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 765940000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 53344000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 2053000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 2053000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Research And Development: 7212000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 11475000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -544831000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 1964000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 5625000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 20428000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Share Issued: 23656335.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Special Income Charges: 449000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 734546000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 719546000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 10757.01
BAFNAPH.NS income_statement (annual, 2023-03-31) — Tax Provision: 2783000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.02
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 142689000.00
BAFNAPH.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -1277000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Total Assets: 1295832000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 818879000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Total Debt: 229239000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 734546000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Total Expenses: 1032815000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 561286000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 422715000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 96523000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 2401000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 812000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 449000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 449000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Work In Process: 51478000.00
BAFNAPH.NS balance_sheet (annual, 2023-03-31) — Working Capital: 408354000.00
BAFNAPH.NS income_statement (annual, 2023-03-31) — Write Off: 3044000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — +Operating Expense: 390316000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — +Total Revenue: 1524657000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 354223000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 453948000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -592754000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 753765000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -8937000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 6993000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 23656000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Basic EPS: 3.11
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 78102000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 251514000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -158482000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 236563000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 13960000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 13960000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 13310000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 650000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -74231000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -18927000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 15100000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Change In Payable: 69619000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -48737000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -52795000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -64142000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Common Stock: 236563000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 808387000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 104958000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 1069072000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Current Assets: 937706000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Current Debt: 136361000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 136361000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 540830000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 12649000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Depreciation: 49954000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 49954000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 49954000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 49954000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 23656000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Diluted EPS: 3.11
BAFNAPH.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 73479000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — EBIT: 92854000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — EBITDA: 142808000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — End Cash Position: 13960000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -8454000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 30649000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -63634000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -657000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 88008000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 17700000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 462885000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 1099828000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Gross Profit: 455585000.00